Polymer–Lipid Pharmaceutical Nanocarriers: Innovations by New Formulations and Production Technologies

Some issues in pharmaceutical therapies such as instability, poor membrane permeability, and bioavailability of drugs can be solved by the design of suitable delivery systems based on the combination of two pillar classes of ingredients: polymers and lipids. At the same time, modern technologies are...

Full description

Bibliographic Details
Main Authors: Sabrina Bochicchio, Gaetano Lamberti, Anna Angela Barba
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:Pharmaceutics
Subjects:
Online Access:https://www.mdpi.com/1999-4923/13/2/198
id doaj-185f08c1818a4286b98c6e175436e47a
record_format Article
spelling doaj-185f08c1818a4286b98c6e175436e47a2021-02-03T00:02:37ZengMDPI AGPharmaceutics1999-49232021-02-011319819810.3390/pharmaceutics13020198Polymer–Lipid Pharmaceutical Nanocarriers: Innovations by New Formulations and Production TechnologiesSabrina Bochicchio0Gaetano Lamberti1Anna Angela Barba2Eng4Life Srl, Spin-Off Accademico, Via Fiorentino, 32, 83100 Avellino, ItalyEng4Life Srl, Spin-Off Accademico, Via Fiorentino, 32, 83100 Avellino, ItalyEng4Life Srl, Spin-Off Accademico, Via Fiorentino, 32, 83100 Avellino, ItalySome issues in pharmaceutical therapies such as instability, poor membrane permeability, and bioavailability of drugs can be solved by the design of suitable delivery systems based on the combination of two pillar classes of ingredients: polymers and lipids. At the same time, modern technologies are required to overcome production limitations (low productivity, high energy consumption, expensive setup, long process times) to pass at the industrial level. In this paper, a summary of applications of polymeric and lipid materials combined as nanostructures (hybrid nanocarriers) is reported. Then, recent techniques adopted in the production of hybrid nanoparticles are discussed, highlighting limitations still present that hold back the industrial implementation.https://www.mdpi.com/1999-4923/13/2/198polymerslipidshybrid nanoparticlesnanotechnologiesproduction technologiesdrug delivery
collection DOAJ
language English
format Article
sources DOAJ
author Sabrina Bochicchio
Gaetano Lamberti
Anna Angela Barba
spellingShingle Sabrina Bochicchio
Gaetano Lamberti
Anna Angela Barba
Polymer–Lipid Pharmaceutical Nanocarriers: Innovations by New Formulations and Production Technologies
Pharmaceutics
polymers
lipids
hybrid nanoparticles
nanotechnologies
production technologies
drug delivery
author_facet Sabrina Bochicchio
Gaetano Lamberti
Anna Angela Barba
author_sort Sabrina Bochicchio
title Polymer–Lipid Pharmaceutical Nanocarriers: Innovations by New Formulations and Production Technologies
title_short Polymer–Lipid Pharmaceutical Nanocarriers: Innovations by New Formulations and Production Technologies
title_full Polymer–Lipid Pharmaceutical Nanocarriers: Innovations by New Formulations and Production Technologies
title_fullStr Polymer–Lipid Pharmaceutical Nanocarriers: Innovations by New Formulations and Production Technologies
title_full_unstemmed Polymer–Lipid Pharmaceutical Nanocarriers: Innovations by New Formulations and Production Technologies
title_sort polymer–lipid pharmaceutical nanocarriers: innovations by new formulations and production technologies
publisher MDPI AG
series Pharmaceutics
issn 1999-4923
publishDate 2021-02-01
description Some issues in pharmaceutical therapies such as instability, poor membrane permeability, and bioavailability of drugs can be solved by the design of suitable delivery systems based on the combination of two pillar classes of ingredients: polymers and lipids. At the same time, modern technologies are required to overcome production limitations (low productivity, high energy consumption, expensive setup, long process times) to pass at the industrial level. In this paper, a summary of applications of polymeric and lipid materials combined as nanostructures (hybrid nanocarriers) is reported. Then, recent techniques adopted in the production of hybrid nanoparticles are discussed, highlighting limitations still present that hold back the industrial implementation.
topic polymers
lipids
hybrid nanoparticles
nanotechnologies
production technologies
drug delivery
url https://www.mdpi.com/1999-4923/13/2/198
work_keys_str_mv AT sabrinabochicchio polymerlipidpharmaceuticalnanocarriersinnovationsbynewformulationsandproductiontechnologies
AT gaetanolamberti polymerlipidpharmaceuticalnanocarriersinnovationsbynewformulationsandproductiontechnologies
AT annaangelabarba polymerlipidpharmaceuticalnanocarriersinnovationsbynewformulationsandproductiontechnologies
_version_ 1724290365452713984